Impact of RNA Stabilization on Minimal Residual Disease Assessment in Chronic Myeloid Leukemia.

I Thörn, U Olsson-Strömberg, C Ohlsen… - 2005 - ashpublications.org
Background and objective: Accurate quantification of BCR-ABL mRNA is of critical
importance for managing chronic myeloid leukemia (CML) patients receiving Imatinib …
被引用次数：34 相关文章

Impact of RNA Stabilization on Minimal Residual Disease Assessment in Chronic Myeloid Leukemia.

I Thörn, U Olsson-Strömberg, C Ohlsen, AM Jonsson… - Blood, 2005 - Elsevier
Background and objective: Accurate quantification of BCR-ABL mRNA is of critical
importance for managing chronic myeloid leukemia (CML) patients receiving Imatinib …

[引用][C] The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia

I THÖRN, U OLSSON-STRÖMBERG… - Haematologica …, 2005 - pascal-francis.inist.fr
The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid
leukemia CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia

I Thörn, U Olsson-Strömberg, C Ohlsen… - …, 2005 - pubmed.ncbi.nlm.nih.gov
Background and objectives Accurate quantification of BCR-ABL mRNA is of critical
importance for managing patients with chronic myeloid leukemia (CML) who are receiving …

The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia

I Thorn, U Olsson-Stromberg, C Ohlsen… - …, 2005 - haematologica.org
BACKGROUND AND OBJECTIVES: Accurate quantification of BCR-ABL mRNA is of critical
importance for managing patients with chronic myeloid leukemia (CML) who are receiving …
[PDF] researchgate.net

[PDF][PDF] The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia

I Thörn, U Olsson-Strömberg, C Ohlsen… - …, 2005 - researchgate.net
Assays based on the detection and quantification of specific RNA are widely used to monitor
therapy response in patients with hematologic malignancies. 1 Since the advent of the …

The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia.

I Thörn, U Olsson-Strömberg, C Ohlsen… - …, 2005 - europepmc.org
Results RNA isolated with the PAXgene system gave a superior yield per milliliter of blood
than did the routine Trizol extraction method. However, although of comparable quality, the …

The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia.

I Thorn, U Olsson-Strömberg, C Ohlsen… - …, 2005 - diva-portal.org
Traditionally, response to treatment in hematological malignancies is evaluated by light
microscopy of bone marrow (BM) smears, but due to more effective therapies more sensitive …

The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia

I Thorn, U Olsson-Stromberg, C Ohlsen… - …, 2005 - haematologica.org
BACKGROUND AND OBJECTIVES: Accurate quantification of BCR-ABL mRNA is of critical
importance for managing patients with chronic myeloid leukemia (CML) who are receiving …

[引用][C] The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia

I THÖRN, U OLSSON-STRÖMBERG… - …, 2005 - Ferrata Storti Foundation